CDMOs: value-based pricing is key to success

Published on February 15, 2021
CDMOs: value-based pricing is key to success Sabrina Mueller Mon, 02/15/2021 - 05:14pm

Body

Many pharmaceutical and biotech companies outsource their product development and manufacturing. In this article, experts from Simon-Kucher & Partners explain why smart offer design and costing is key to commercial success for CDMOs.

News URL

https://www.europeanpharmaceuticalreview.com/article/142979/cdmos-value-based-p…
Other news

TopLine 2021 Life Sciences

February 15, 2021
TopLine 2021 Life SciencesEmma HarteMon, 02/15/2021 - 11:16am Share: Facebook Twitter LinkedIn Print this page Hero Banner The Future of Life Sciences: Successful TopLine Growth in HealthcareJoin us on the 18th of May for Simon-Kucher & Partners' new virtual conference!The Life Science industry will face

Embracing the Change: Revisiting Simon-Kucher 2020 China NRDL Predictions

February 16, 2021
Embracing the Change: Revisiting Simon-Kucher 2020 China NRDL Predictions China’s 2020 NRDL (National Reimbursement Drug List) results are out, marking many firsts in history. In this article, we revisit the three themes and five predictions from our NRDL perspectives last October, and cordially invite you for a quick survey on its future outlook.China doesn’t take a break over Christma